Transaction #30846 · Form 4 · 0001231919-26-001426
Vor Biopharma Inc. · Exercise / conversion · Common Stock
Vor Biopharma Inc. · Transacted October 2, 2026 · Filed October 5, 2026
What does this filing report?
An SEC Form 4 filing for Vor Biopharma Inc. records an exercise / conversion involving Common Stock on October 2, 2026. The reported quantity was 500. The filing date is October 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Vor Biopharma Inc.
- Company CIK
- 0001817229
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 500
- Reported price
- 12.8
- Reference value
- 6,400
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 500
- Ownership description
- See footnotes
- SEC acceptance time
- Oct 5, 2026, 6:52 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- RA Capital Healthcare Fund LP ↗
10% owner
CIK 0001315082
- RA CAPITAL MANAGEMENT, L.P. ↗
10% owner
CIK 0001346824
- Kolchinsky Peter ↗
10% owner
CIK 0001384859
- Shah Rajeev M. ↗
10% owner
CIK 0001619841
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- F2
- This option was granted to Andrew Levin pursuant to the Issuer's non-employee director compensation policy. Under Dr. Levin's arrangement with the Adviser, Dr. Levin held the option for the benefit of the Fund. Dr. Levin is obligated to turn over to the Adviser any stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.
- F3
- The shares held by the Fund prior to the transactions reported herein reflect the receipt of shares previously held by the Adviser to offset advisory fees owed by the Fund to the Adviser. The receipt of such shares by the Fund constituted a change in form of ownership and, therefore, was not required to be reported pursuant to Section 16.
- F4
- Held directly by the Fund.
- F5
- Immediately exercisable.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.